UNSPSC 51282321: Erythromycin glucoheptonate

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2AY21R0U64. European Medicines Agency schedules Erythromycin gluceptate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01943MIG. Erythromycin glucoheptonate generally arises in the molecular formula C37H67NO13.C7H14O8. The term 'erythromycin glucoheptonate' is a U.S. Pharmacopeial Convention designation.

Most nations, for tariff and trade purposes, schedule erythromycin glucoheptonate under HS 29415000 and SITC 54139. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)O)O)O)O)O)O)O.

UNSPSC 51282321 Erythromycin glucoheptonate, a Commodity code, nominally describes a specific injectable antibiotic, but state and local procurement activity under this code shows little alignment with that narrow scope. The recent opportunities tagged to this code span naloxone procurement, medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and exploratory vendor engagement around direct-to-manufacturer prescription models — none of which involve erythromycin glucoheptonate specifically. State and local governments do purchase pharmaceuticals and medical supplies, but the actual work being solicited under this code designation does not reflect the product name; the tagging appears to be a data-quality issue rather than active procurement demand for the specific antibiotic formulation.

The issuing bodies in recent opportunities include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (MMCAP, spanning Minnesota and participating states including Oregon). Geographic activity is concentrated in Florida, Texas, and the upper Midwest where cooperative purchasing is active. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's IFB for medical and first aid supplies for the Fire Department Rescue Division with a $700,000 estimated contract value and SLBE set-aside (due March 13, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities (due March 26, 2026). The mismatch between the commodity code name and the actual procurement activity suggests this code should not be treated as a reliable indicator of current demand for erythromycin glucoheptonate.